NCT07253532 Vibrotactile Balance Belt Effect on Improving Gait
| NCT ID | NCT07253532 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Vestibular Hypofunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-03-20 |
| Primary Completion | 2030-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-03-20 with a primary completion date of 2030-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the effect of using a vibrotactile feedback implemented into a belt, at improving gait in those with gait disorders.
Eligibility Criteria
Inclusion Criteria: * Age 18-80 years old * Waist between 60 and 120 cm * Intact vibration sensitivity around the waist * Balance disorder and/or a diagnosis of ataxia or vestibular dysfunction (diagnosis based on imaging, clinical and family history, vestibular function tests, and/or genetic testing) * Speak English Exclusion Criteria: * Previous Vestibular Rehabilitation Therapy (VRT) finished less than 2 months ago * Inability to stand or walk slowly without support in the light on a firm underground * Neurological, ophthalmological and/or orthopedic disorders that hampers vestibular, oculomotor or gait and posture examination
Contact & Investigator
Jennifer Millar, MD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT07253532 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Vestibular Hypofunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07253532 currently recruiting?
Yes, NCT07253532 is actively recruiting participants. Contact the research team at mschube1@jhmi.edu for enrollment information.
Where is the NCT07253532 trial being conducted?
This trial is being conducted at Baltimore, United States, Baltimore, United States.
Who is sponsoring the NCT07253532 clinical trial?
NCT07253532 is sponsored by Johns Hopkins University. The principal investigator is Jennifer Millar, MD at Johns Hopkins University. The trial plans to enroll 90 participants.